The Growth of Biologic Therapies Innovation, Effectiveness
The Growth of Biologic Therapies: Innovation, Effectiveness, and Barriers to Access Biological therapy changes how complex diseases are treated by offering more targeted and effective alternatives. In this article sees recent advances in biology, their increasing use in conditions such as cancer and autoimmune diseases and the growing role of biosimilars. It also discusses major…
divyaochre
Strategic Alliances in AI Drug Discovery
Companies for Artificial intelligence-driven drug discovery (AIDD) have the ability to change drug growth. However, there is still a limited understanding of how these companies administer partnerships with established pharmaceutical companies. Effective cooperation depends on the creation of strong relationship skills. The most important elements include adjustment of complementary strength, establishment of clear management structures,…
Navigating EMA PMS Requirements: A Strategic Guide for Regul
Navigating EMA PMS Requirements: A Strategic Guide for Regulatory Leaders. Authors: Manfred Voglmaier – ACCURIDS Raphael Sergent – ACCURIDS Michiel Stam—MAIN5 Dominik Gigli – MAIN5 A Strategic Guide for Regulatory Leaders. Regulatory requirements in the pharmaceutical industry are becoming more stringent. By 2026, IDMP compliance will become drastically more challenging for all pharmaceutical companies operating in the EU…
Why Biosimilars are changing the Pharmaceutical Industry
The pharmaceutical industry shifts due to biosimilars because these products extend medical treatment access to crucial therapeutics and minimize healthcare expenses through affordable versions of high-cost biologics. The pharmaceutical industry experiences fundamental changes because U.S. Biosimilars secure multiple regulatory approvals for exact versions of approved biologic drugs which lowers healthcare expenditures globally through their inexpensive…
Contract Manufacturing in Biopharma Evolving Beyond COVID-19
The COVID-19 pandemic catalyzed changes to the biopharma manufacturing landscape, with agility, innovation, and resilience becoming necessary prerequisites. And digital transformation, single-use technologies, and strategic partnerships were driving contract manufacturing that soared. Demand is rebounding, but regulatory changes and automation are reshaping the industry. Welcome to the future, where the nature of demand is shifting,…
Data-Enriched Edible Pharmaceuticals (DEEP)
Data-Enriched Edible Pharmaceuticals (DEEP) as Patient-Tailored Drug Products AUTHORS: Natalja Genina, Associate Professor, University of Copenhagen (UCPH) Jukka Rantanen, Professor, UCPH Johan Bøtker, Associate Professor, UCPH Sofia Kalvemark Sporrong, Professor, Uppsala University Data-enriched edible pharmaceuticals (DEEP) is a novel pharmaceutical product design principle. DEEP has been proposed as a solution for personalized medicines, where each drug product, i.e., ‘every…
Optimizing Portfolio Management in Pharma CDMOs Strategies
Optimizing Portfolio Management in Pharma CDMOs: Strategies for Sustainable Growth Author: Deepak Khurana, CPSCM™ is a Vice President Procurement & SCM, Suven Pharmaceuticals In the competitive and regulated pharmaceutical industry, effective portfolio management is critical for contract development and manufacturing organizations (CDMOs) aiming for sustained growth and long-term success. This article explores strategies to optimize…
How AI is Transforming the Pharmaceutical Industry
Authors: Chandramouli Ramnarayanan, PhD, Global Technical Enablement Engineer, JMP Statistical Discovery LLC Dr. Valliappan Kannappan, Founder, Chiralpedia Artificial Intelligence (AI) is revolutionizing Europe’s pharmaceutical landscape by accelerating drug discovery, streamlining clinical trials, and enhancing personalized patient care. Innovations from companies like Exscientia and Healx significantly shorten development timelines, while regulators grapple with balancing rapid innovation against ethical…
Nano-Carrier based Smart Drug Delivery Systems
Nano-Carrier based Smart Drug Delivery Systems: Taking Aim at Cancer Therapy Sidharth Mehta, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and & Technology Nikita Yadav, Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science & Technology The creation of smart nanocarrier-based drug delivery systems, also known as Smart Drug Delivery Systems(SDDSs), was prompted by the…
- 1
- 2